Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: tempelife
7
Jan 01, 2008 11:27AM
2
Jan 01, 2008 12:19PM
2
Jan 01, 2008 01:47PM
1
Jan 01, 2008 02:03PM

The non-final action enables TPL/Moore to respond to the claimed obviousness, as they did with the '336, which also used INMOS as claimed prior art.

The USPTO site has been down for a few days.

I'll wait and see the response before guessing how strong the '148 will be - remember it could takes years to resolve if TPL/Moore have to go through the whole appeal process. There again, it could be months if their submission convinces the examiner that the cited prior art is not obvious.

 

 

 

Be well

Share
New Message
Please login to post a reply